TransMedics Group, Inc. Forecast, price target & analysts
TransMedics Group, Inc. Target price 2025 - Analyst rating & recommendation
TransMedics Group, Inc. Classifications & Recommendation:
TransMedics Group, Inc. Price Target
| Target Price | $145.35 |
| Price | $131.45 |
| Potential |
10.57%
register free of charge
|
| Number of Estimates | 11 |
|
11 Analysts have issued a price target TransMedics Group, Inc. 2026 .
The average TransMedics Group, Inc. target price is $145.35.
This is
10.57%
register free of charge
$187.95
42.98%
register free of charge
$104.03
20.86%
register free of charge
|
|
| A rating was issued by 16 analysts: 12 Analysts recommend TransMedics Group, Inc. to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the TransMedics Group, Inc. stock has an average upside potential 2026 of
10.57%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 441.54 | 591.98 |
| 82.74% | 34.07% | |
| EBITDA Margin | 8.54% | 19.84% |
| 3,396.65% | 132.36% | |
| Net Margin | 8.03% | 10.53% |
| 177.52% | 31.12% |
12 Analysts have issued a sales forecast TransMedics Group, Inc. 2025 . The average TransMedics Group, Inc. sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an TransMedics Group, Inc. EBITDA forecast 2025. The average TransMedics Group, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
12 TransMedics Group, Inc. Analysts have issued a net profit forecast 2025. The average TransMedics Group, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 1.01 | 1.84 |
| 231.17% | 82.18% | |
| P/E | 71.34 | |
| EV/Sales | 7.85 |
12 Analysts have issued a TransMedics Group, Inc. forecast for earnings per share. The average TransMedics Group, Inc. EPS is
This results in the following potential growth metrics and future valuations:
TransMedics Group, Inc....
Current TransMedics Group, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Needham |
Locked
➜
Locked
|
Locked | Jun 17 2025 |
| Oppenheimer |
Locked
➜
Locked
|
Locked | Jun 17 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Jun 04 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Jun 03 2025 |
| Oppenheimer |
Locked
➜
Locked
|
Locked | May 09 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | May 09 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Apr 29 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Needham:
Locked
➜
Locked
|
Jun 17 2025 |
|
Locked
Oppenheimer:
Locked
➜
Locked
|
Jun 17 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Jun 04 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Jun 03 2025 |
|
Locked
Oppenheimer:
Locked
➜
Locked
|
May 09 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
May 09 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Apr 29 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
